Guardian Pharmacy Services provides pharmacy dispensing and medication management services to residents of long term care facilities. GRDN reports earnings on Thu, Nov 5, 2026. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell).
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 23 | Keybanc | Initiated | Buy | |
| Sep 21 | Truist Securities | Target raised | Buy | |
| Aug 7 | Oppenheimer | Maintained | Buy | |
| Jun 17 | Truist Securities | Maintained | Buy | |
| Jun 17 | B of A Securities | Target raised | Buy |
Whale Options Flow
90DNo whale options trades in GRDN in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GRDN is in one of them and how their past GRDN trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered GRDN in an article yet. Here's the latest on the wider market.
About Guardian Pharmacy Services
Guardian Pharmacy Services is a pharmacy services company based in Atlanta, Georgia. It dispenses, packages and delivers prescription medications to residents of long term care facilities, with a focus on assisted living facilities and behavioral health facilities. Its services include compliance packaging, automated robotic dispensing, medication administration training for facility staff and drug regimen reviews. Its customers include the residents, the facilities that house them and health plan payors.
- Headquarters
- Atlanta, GA